What is the price target for DAVA stock?
14 analysts have analysed DAVA and the average price target is 10.12 USD. This implies a price increase of 133.06% is expected in the next year compared to the current price of 4.34.
NYSE:DAVA • US29260V1052
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ENDAVA PLC- SPON ADR (DAVA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-20 | JP Morgan | Maintains | Neutral -> Neutral |
| 2026-02-19 | Needham | Maintains | Buy -> Buy |
| 2026-02-13 | Guggenheim | Maintains | Buy -> Buy |
| 2025-11-13 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-12 | Guggenheim | Maintains | Buy -> Buy |
| 2025-11-12 | Needham | Maintains | Buy -> Buy |
| 2025-11-12 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-11-11 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-09-05 | Guggenheim | Maintains | Buy -> Buy |
| 2025-09-05 | Needham | Maintains | Buy -> Buy |
| 2025-09-05 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-28 | Guggenheim | Maintains | Buy -> Buy |
| 2025-08-20 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-07-17 | Deutsche Bank | Reiterate | Hold |
| 2025-06-10 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-06-10 | Needham | Maintains | Buy -> Buy |
| 2025-05-20 | Susquehanna | Maintains | Positive -> Positive |
| 2025-05-19 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-05-15 | Needham | Maintains | Buy -> Buy |
| 2025-05-13 | Guggenheim | Maintains | Buy -> Buy |
| 2025-02-21 | Needham | Maintains | Buy -> Buy |
| 2025-02-21 | Susquehanna | Maintains | Positive -> Positive |
| 2025-01-31 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-10 | Needham | Maintains | Buy -> Buy |
| 2024-11-22 | B of A Securities | Initiate | Neutral |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 794.7M 21.37% | 740.756M -6.79% | 772.255M 4.25% | 754.07M -2.35% | 786.45M 4.29% | 820.53M 4.33% | 799.85M -2.52% | 839.85M 5.00% | 881.85M 5.00% | 925.95M 5.00% | 972.25M 5.00% | |
| EBITDA YoY % growth | 146.8M 17.53% | 58.951M -59.84% | 76.578M 29.90% | 87.9M 14.78% | 103.53M 17.78% | 117.15M 13.16% | 114.73M -2.07% | 120.72M 5.22% | 126.71M 4.96% | 133.69M 5.51% | 139.68M 4.48% | |
| EBIT YoY % growth | 113.7M 18.31% | 20.14M -82.29% | 31.507M 56.44% | 66.378M 110.68% | 77.545M 16.82% | 82.11M 5.89% | 99.968M 21.75% | 104.96M 4.99% | 110.24M 5.03% | 115.73M 4.98% | 121.52M 5.00% | |
| Operating Margin | 14.31% | 2.72% | 4.08% | 8.80% | 9.86% | 10.01% | 12.50% | 12.50% | 12.50% | 12.50% | 12.50% | |
| EPS YoY % growth | 2.27 17.01% | 1.13 -50.22% | 1.13 0.33% | 0.82 -27.24% | 1.02 23.39% | 1.16 13.96% | 1.29 10.95% | 1.35 4.65% | 1.40 3.70% | 1.47 4.99% | 1.54 4.76% |
All data in GBP
| Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.21 -39.16% | 0.31 27.12% | 0.23 50.88% | 0.24 52.37% | 0.26 26.53% | 0.29 -5.29% | 0.27 18.94% | 0.29 18.23% | 0.32 21.03% | 0.42 46.85% |
| Revenue Q2Q % growth | 187.43M -3.80% | 198.54M 6.30% | 195.74M 9.85% | 194.5M 5.65% | 197M 5.11% | 201.68M 1.58% | 199.92M 2.14% | 200.94M 3.31% | 208.08M 5.62% | 219.3M 8.74% |
| EBITDA Q2Q % growth | 21.795M -31.78% | 28.107M 8.06% | 25.547M 21.19% | 26.278M 36.61% | 27.441M 25.91% | 30.521M 8.59% | 25.5M -0.18% | 26.52M 0.92% | 28.56M 4.08% | 35.7M 16.97% |
| EBIT Q2Q % growth | 16.496M 0.26% | 21.779M 150.62% | 16.53M 667.85% | 17.027M 676.40% | 17.874M 8.35% | 21.045M -3.37% | 17.34M 4.90% | 18.36M 7.83% | 19.38M 8.43% | 26.52M 26.02% |
All data in GBP
14 analysts have analysed DAVA and the average price target is 10.12 USD. This implies a price increase of 133.06% is expected in the next year compared to the current price of 4.34.
ENDAVA PLC- SPON ADR (DAVA) will report earnings on 2026-05-04, before the market open.
The consensus EPS estimate for the next earnings of ENDAVA PLC- SPON ADR (DAVA) is 0.21 USD and the consensus revenue estimate is 187.43M USD.
The consensus rating for ENDAVA PLC- SPON ADR (DAVA) is 75.7143 / 100 . This indicates that analysts generally have a positive outlook on the stock.